Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
M. McDonnell, M. Ahmed, D. Wall, J. Bruzzi, M. O'Mahoney, D. Breen, A. O'Regan, J. J. Gilmartin, R. Rutherford (Galway, Ireland). Prevalence of hiatus hernia in non-cystic fibrosis bronchiectasis and associations with disease severity. Eur Respir J 2013; 42: Suppl. 57, 2709

Member's Comments

No comment yet.

Related content which might interest you: Comparative analysis of the predictive utility of clinical disease severity scores for non-cystic fibrosis bronchiectasis Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections Year: 2014 Impact of co-morbidities on disease severity and risk of mortality in non-cystic fibrosis bronchiectasis Source: International Congress 2015 – Adult bronchiectasis: risk factors and future perspectives Year: 2015 Multiple faces of non-cystic fibrosis bronchiectasis: defining etiology and disease severity Source: International Congress 2017 – Management of asthma in different situations Year: 2017 In patients with idiopathic pulmonary fibrosis the presence of hiatus hernia is associated with disease progression and mortality Source: Eur Respir J, 53 (5) 1802412; 10.1183/13993003.02412-2018 Year: 2019 Is etiology of non-cystic fibrosis bronchiectasis (NCFBE) a risk factor for severe exacerbation? Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections Year: 2014 Clinical characteristics and survival in patients with idiopathic pulmonary fibrosis with and without associated emphysema Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view Year: 2013 Familial pulmonary fibrosis: Clinical-functional and radiological features Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities Year: 2013 Non-pulmonary comorbidities in idiopathic pulmonary fibrosis Source: International Congress 2015 – IPF: clinical aspects Year: 2015 Understanding patients’ experience of living with non-cystic fibrosis bronchiectasis Source: Annual Congress 2013 –Aspects of physiotherapy in various clinical conditions and settings Year: 2013 Co-existent rheumatoid arthritis and non-cystic fibrosis bronchiectasis: Evidence for more severe pulmonary disease using the bronchiectasis severity index (BSI) Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections Year: 2014 Course of disease and cause of death in patients with idiopathic pulmonary fibrosis in Eastern Finland Source: International Congress 2015 – IPF: clinical aspects Year: 2015 Exacerbations of bronchiectasis: Etiology and outcome Source: International Congress 2016 – Orphan diseases II Year: 2016 Cystic fibrosis and arthritis in children Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children Year: 2013 Prognostic significance of selected biomarkers in idiopathic pulmonary fibrosis, sarcoidosis, and chronic pulmonary obstructive disease Source: International Congress 2014 – Sarcoidosis Year: 2014 Bronchiectasis: epidemiology and causes Source: Eur Respir Mon 2011; 52: 1-10 Year: 2011 Prevalence of bronchiectasis in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 60s Year: 2006 High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis Source: Eur Respir J 2006; 27: 136-142 Year: 2006 DLCO predicts disease severity and mortality in patients with non-cystic fibrosis bronchiectasis Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical aspects and research outlook Year: 2015 Thrombocytosis is associated with disease severity and outcomes in stable bronchiectasis Source: International Congress 2015 – Adult bronchiectasis: risk factors and future perspectives Year: 2015